Showing results (61-70 of 124) with videos related to
Sort By:
Pageof 13
European Heart Journal|February 28, 2016
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillationZiad Hijazi, Johan Lindbäck, John H Alexander, et al.Journal of the American Heart Association|February 9, 2018
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TrialTymon Pol, Claes Held, Johan Westerbergh, et al.International Journal of Cardiology|November 18, 2016
Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trialPatrícia O Guimarães, Daniel M Wojdyla, John H Alexander, et al.Journal of the American College of Cardiology|August 11, 2018
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE SubstudyJohn D Horowitz, Raffaele De Caterina, Tamila Heresztyn, et al.International Journal of Cardiology|January 15, 2020
Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trialM Cecilia Bahit, Christopher B Granger, John H Alexander, et al.Biochemistry|November 22, 2017
Dynamic Glycosylation Governs the Vertebrate COPII Protein Trafficking PathwayNathan J Cox, Gokhan Unlu, Brittany J Bisnett, et al.Journal of the American Heart Association|June 25, 2017
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over TimeZiad Hijazi, Bertil Lindahl, Jonas Oldgren, et al.The American Journal of Medicine|July 26, 2017
Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE TrialChiara Melloni, Allison Dunning, Christopher B Granger, et al.Clinical Cardiology|March 26, 2019
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trialPatricia O Guimarães, Sean D Pokorney, Renato D Lopes, et al.American Heart Journal|September 1, 2014
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialShinya Goto, Jun Zhu, Lisheng Liu, et al.Pageof 13